Clinical Trial Update: Dynamic Contrast Enhanced HCC SABR Liver Study [NA]

View source ↗

Summary

Clinical trial update for a dynamic contrast-enhanced SABR liver study in hepatocellular carcinoma; the study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Carcinoma, Hepatocellular | NA | Status: UNKNOWN